These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19731917)

  • 1. Structure-activity relationships of adenine and deazaadenine derivatives as ligands for adenine receptors, a new purinergic receptor family.
    Borrmann T; Abdelrahman A; Volpini R; Lambertucci C; Alksnis E; Gorzalka S; Knospe M; Schiedel AC; Cristalli G; Müller CE
    J Med Chem; 2009 Oct; 52(19):5974-89. PubMed ID: 19731917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for the functional expression and pharmacological characterization of adenine receptors in native cells and tissues.
    Gorzalka S; Vittori S; Volpini R; Cristalli G; von Kügelgen I; Müller CE
    Mol Pharmacol; 2005 Mar; 67(3):955-64. PubMed ID: 15604413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Aryl-8-azaadenosines: structure-activity relationships in the binding with A1 and A2 receptors. A comparison with the corresponding 9-benzyl-8-azaadenines. III.
    Biagi G; Giorgi I; Livi O; Scartoni V; Lucacchini A; Martini C; Tacchi P
    Farmaco; 1994 Feb; 49(2):93-6. PubMed ID: 8003186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and pharmacology of pyrido[2,3-d]pyrimidinediones bearing polar substituents as adenosine receptor antagonists.
    Bulicz J; Bertarelli DC; Baumert D; Fülle F; Müller CE; Heber D
    Bioorg Med Chem; 2006 Apr; 14(8):2837-49. PubMed ID: 16377196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,3-dialkyl-8-N-substituted benzyloxycarbonylamino-9-deazaxanthines as potent adenosine receptor ligands: Design, synthesis, structure-affinity and structure-selectivity relationships.
    Fernández F; Caamaño O; Isabel Nieto M; López C; García-Mera X; Stefanachi A; Nicolotti O; Isabel Loza M; Brea J; Esteve C; Segarra V; Vidal B; Carotti A
    Bioorg Med Chem; 2009 May; 17(10):3618-29. PubMed ID: 19398343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and functional expression of a novel Gi protein-coupled receptor for adenine from mouse brain.
    von Kügelgen I; Schiedel AC; Hoffmann K; Alsdorf BB; Abdelrahman A; Müller CE
    Mol Pharmacol; 2008 Feb; 73(2):469-77. PubMed ID: 17975009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N(6)-substituted 2-phenyl-9-benzyl-8-azaadenines. Affinity for adenosine A1 and A2 receptors. A comparison with 2-N-butyl analogous derivatives. V.
    Biagi G; Giorgi I; Livi O; Scartoni V; Lucacchini A; Martini C; Tacchi P
    Farmaco; 1994 Mar; 49(3):187-91. PubMed ID: 8043170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of new 2-phenyladenines and 2-phenylpteridines and biological evaluation as adenosine receptor ligands.
    Giorgi I; Biagi G; Livi O; Leonardi M; Scartoni V; Pietra D
    Arch Pharm (Weinheim); 2007 Feb; 340(2):81-7. PubMed ID: 17294400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, biological activity and molecular modelling of new trisubstituted 8-azaadenines with high affinity for A1 adenosine receptors.
    Giorgi I; Bianucci AM; Biagi G; Livi O; Scartoni V; Leonardi M; Pietra D; Coi A; Massarelli I; Nofal FA; Fiamingo FL; Anastasi P; Giannini G
    Eur J Med Chem; 2007 Jan; 42(1):1-9. PubMed ID: 17028066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of hybrid analogues of caffeine and eudistomin D and its affinity for adenosine receptors.
    Ishiyama H; Nakajima H; Nakata H; Kobayashi J
    Bioorg Med Chem; 2009 Jul; 17(13):4280-4. PubMed ID: 19481943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on affinity profile toward native human and bovine adenosine receptors of a series of 1,8-naphthyridine derivatives.
    Ferrarini PL; Betti L; Cavallini T; Giannaccini G; Lucacchini A; Manera C; Martinelli A; Ortore G; Saccomanni G; Tuccinardi T
    J Med Chem; 2004 Jun; 47(12):3019-31. PubMed ID: 15163184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and pharmacological evaluation of novel 1- and 8-substituted-3-furfuryl xanthines as adenosine receptor antagonists.
    Balo MC; Brea J; Caamaño O; Fernández F; García-Mera X; López C; Loza MI; Nieto MI; Rodríguez-Borges JE
    Bioorg Med Chem; 2009 Sep; 17(18):6755-60. PubMed ID: 19682912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and adenosine receptor binding studies of some novel triazolothienopyrimidines.
    Raghu Prasad M; Raghuram Rao A; Shanthan Rao P; Rajan KS; Meena S; Madhavi K
    Eur J Med Chem; 2008 Mar; 43(3):614-20. PubMed ID: 17602796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of adenosines with heterocyclic N6-substituents.
    Ashton TD; Aumann KM; Baker SP; Schiesser CH; Scammells PJ
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6779-84. PubMed ID: 17967536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of specific [3H]adenine-binding sites in rat brain membranes.
    Watanabe S; Ikekita M; Nakata H
    J Biochem; 2005 Mar; 137(3):323-9. PubMed ID: 15809333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of valerian extracts of different polarity with adenosine receptors: identification of isovaltrate as an inverse agonist at A1 receptors.
    Lacher SK; Mayer R; Sichardt K; Nieber K; Müller CE
    Biochem Pharmacol; 2007 Jan; 73(2):248-58. PubMed ID: 17097622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,2,3-Triazolo [4,5-d] pyridazines--V. Preparation and adenosine receptor binding of new 4-amino derivatives.
    Biagi G; Giorgi I; Livi O; Manera C; Scartoni V; Lucacchini A; Senatore G
    Farmaco; 1996; 51(8-9):601-8. PubMed ID: 8930114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N(6)-substituted 2-N-butyl-9-benzyl-8-azaadenines. Affinity for adenosine A1 and A2 receptors. IV.
    Biagi G; Giorgi I; Livi O; Scartoni V; Lucacchini A; Martini C; Tacchi P
    Farmaco; 1994 Mar; 49(3):183-6. PubMed ID: 8043169
    [No Abstract]   [Full Text] [Related]  

  • 19. Adenosine A2A receptor antagonists: new 8-substituted 9-ethyladenines as tools for in vivo rat models of Parkinson's disease.
    Volpini R; Dal Ben D; Lambertucci C; Marucci G; Mishra RC; Ramadori AT; Klotz KN; Trincavelli ML; Martini C; Cristalli G
    ChemMedChem; 2009 Jun; 4(6):1010-9. PubMed ID: 19343763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrido[2,3-e]-1,2,4-triazolo[4,3-a]pyrazin-1-one as a new scaffold to develop potent and selective human A3 adenosine receptor antagonists. Synthesis, pharmacological evaluation, and ligand-receptor modeling studies.
    Colotta V; Lenzi O; Catarzi D; Varano F; Filacchioni G; Martini C; Trincavelli L; Ciampi O; Pugliese AM; Traini C; Pedata F; Morizzo E; Moro S
    J Med Chem; 2009 Apr; 52(8):2407-19. PubMed ID: 19301821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.